Otopeni handling companies raked in revenues worth almost RON340 million in 2024, up 20% yoy.
Dr. Max Group, which includes the pharmacies of the same name and drug wholesaler Mediplus, ended 2024 with over EUR2 billion (RON10.7 billion) turnover, after a 23% advance from 2023.